Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.53Latest market snapshot
Implied fair value · at GNL's multiple
$48.0410.4% above market
12.37 SUPN revenue / share×3.88x GNL P/S=$48.04
Market $43.53Implied $48.04
GNL · current priceP/S 3.88x
$9.12Latest market snapshot
Implied fair value · at SUPN's multiple
$8.269.4% below market
2.35 GNL revenue / share×3.52x SUPN P/S=$8.26
Market $9.12Implied $8.26